Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
OrthopedicSpinal Implant

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1777532

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1777532

Sacroiliac Joint Fusion Injections and RF Ablation

PUBLISHED:
PAGES: 364 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Sacroiliac Joint Fusion Injections and RF Ablation Market to Reach US$1.5 Billion by 2030

The global market for Sacroiliac Joint Fusion Injections and RF Ablation estimated at US$498.4 Million in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 20.1% over the analysis period 2024-2030. Degenerative Sacroilitis, one of the segments analyzed in the report, is expected to record a 22.0% CAGR and reach US$989.3 Million by the end of the analysis period. Growth in the Sacral Disruption segment is estimated at 16.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$135.8 Million While China is Forecast to Grow at 26.6% CAGR

The Sacroiliac Joint Fusion Injections and RF Ablation market in the U.S. is estimated at US$135.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$345.4 Million by the year 2030 trailing a CAGR of 26.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 14.8% and 18.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.1% CAGR.

Global Sacroiliac Joint Fusion Injections and RF Ablation Market - Key Trends & Drivers Summarized

What Are Sacroiliac Joint Fusion Injections and RF Ablation, and Why Are They Key to Non-Surgical SI Joint Pain Management?

Sacroiliac (SI) joint injections and radiofrequency (RF) ablation are two leading non-surgical interventions used for the diagnosis and management of SI joint-related pain, a significant contributor to chronic low back pain. SI joint injections involve the targeted delivery of corticosteroids and/or anesthetics directly into the joint to reduce inflammation and provide temporary pain relief. They are also used diagnostically to confirm SI joint pathology when pain relief is observed following the injection. In contrast, RF ablation uses high-frequency electrical currents to heat and disable the sensory nerves transmitting pain signals from the SI joint, offering longer-lasting relief than injections.

Both techniques serve as critical therapeutic steps before considering surgical sacroiliac joint fusion. They are commonly performed in outpatient settings under image guidance (fluoroscopy or CT) for precision and safety. These interventions are particularly valuable for patients who are not immediate surgical candidates, wish to delay surgery, or have comorbidities that complicate operative procedures. As SI joint pain becomes more clinically recognized and diagnostic accuracy improves, these non-surgical procedures are gaining traction as frontline solutions in multidisciplinary pain management strategies.

How Are Innovations Enhancing the Effectiveness and Safety of SI Joint Injections and RF Ablation?

Technological advancements are refining both SI joint injections and RF ablation techniques, improving their precision, efficacy, and duration of pain relief. Injections now leverage ultrasound-guided and image-fusion techniques, allowing for more accurate needle placement and reduced risk of nerve or vascular injury. The use of long-acting corticosteroids and biologic injectables-such as platelet-rich plasma (PRP) and stem cell formulations-is being explored to prolong anti-inflammatory effects and promote joint healing beyond temporary symptom suppression.

In RF ablation, significant innovation is occurring in electrode design, ablation algorithms, and procedural techniques. Cooled RF ablation is emerging as a superior method, offering larger lesion sizes and improved treatment of variable nerve anatomy, which is especially beneficial for the sacral lateral branches responsible for SI joint innervation. Pulsed RF and multi-lesion RF probes are also being investigated to minimize tissue damage while extending the duration of pain relief. Additionally, real-time nerve mapping and neuromodulation technologies are enhancing the specificity of nerve targeting during ablation procedures.

Patient comfort and safety are being further improved with the development of disposable, sterile RF kits, automated ablation consoles, and integrated pain management software platforms that streamline treatment planning and post-procedural follow-up. These innovations are making SI joint interventions more consistent, reproducible, and appealing to both pain specialists and interventional spine physicians.

Which Patient Populations and Clinical Use Cases Are Driving Market Demand?

The demand for SI joint injections and RF ablation is increasing among diverse patient demographics, particularly among adults aged 40 and above who are more prone to sacroiliac degeneration, postural stress, or trauma-induced dysfunction. Patients with a history of lumbar spine surgery-especially lumbar fusion-are at elevated risk of developing adjacent SI joint pain and often turn to non-surgical interventions before considering revision surgery. Similarly, women experiencing postpartum pelvic pain due to ligamentous laxity or biomechanical strain are increasingly being referred for these procedures.

These interventions are also gaining popularity among athletes and active individuals who seek quicker recovery and want to avoid surgical downtime. In elderly patients or those with multiple comorbidities, where surgery poses higher risks, injections and RF ablation serve as valuable long-term management tools. Moreover, the increasing prevalence of obesity, osteoarthritis, and sedentary lifestyle-induced joint dysfunction is broadening the patient base for SI joint pain treatment.

Healthcare systems are increasingly integrating SI joint injections and ablation into chronic pain management programs, supported by evidence-based care pathways and insurance coverage in most developed markets. Multidisciplinary spine clinics and ambulatory surgery centers are becoming hubs for these procedures, given their minimally invasive nature, low complication rates, and strong cost-effectiveness profile.

What Is Driving the Growth of the Global Sacroiliac Joint Fusion Injections and RF Ablation Market?

The growth in the global sacroiliac joint fusion injections and RF ablation market is driven by several factors, including rising prevalence of SI joint dysfunction, increased clinical awareness and diagnostic accuracy, and growing demand for non-surgical pain management alternatives. The expansion of minimally invasive interventional pain practices, coupled with patient preference for outpatient, low-risk procedures, is accelerating market adoption.

Technological advancements in image-guided intervention, nerve ablation systems, and regenerative injectables are enhancing treatment outcomes and broadening use cases. Additionally, supportive reimbursement frameworks in North America, Europe, and increasingly in Asia-Pacific are encouraging wider use in both public and private healthcare systems. The integration of SI joint procedures into multidisciplinary care models for low back pain, along with a shift toward value-based healthcare and opioid-sparing strategies, is further boosting the demand for injections and RF ablation.

As spine and pain specialists increasingly recognize the sacroiliac joint as a significant source of chronic pain, the role of targeted, image-guided interventions continues to grow. With ongoing innovation, rising patient demand for minimally invasive solutions, and expanding clinical application, the SI joint injections and RF ablation market is poised for sustained global expansion in the years ahead.

SCOPE OF STUDY:

The report analyzes the Sacroiliac Joint Fusion Injections and RF Ablation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (Degenerative Sacroilitis, Sacral Disruption, Trauma); Type (Diagnosis, Treatment); End-Use (Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Aesculap Implant Systems, LLC
  • Amedica Corporation
  • Aurora Spine Corporation
  • Boston Scientific Corporation
  • CornerLoc
  • Globus Medical, Inc.
  • Life Spine, Inc.
  • Medtronic plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • PainTEQ
  • RTI Surgical Holdings, Inc.
  • SI-BONE, Inc.
  • Stratus Medical
  • Surgalign Holdings, Inc.
  • Tenon Medical, Inc.
  • Xtant Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Zyga Technology, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP32860

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Sacroiliac Joint Fusion Injections and RF Ablation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Sacroiliac Joint Dysfunction Drives Demand for Sacroiliac Joint Fusion Injections and RF Ablation
    • Surge in Minimally Invasive Spine Procedures Accelerates Market Adoption of Sacroiliac Joint Fusion Injections and RF Ablation
    • Rising Patient Demand for Non-Surgical, Effective Pain Management Options Propels Growth in Sacroiliac Joint Injections and RF Ablation
    • Technological Advancements in Radiofrequency Ablation Techniques Strengthen the Business Case for RF Ablation in Sacroiliac Joint Pain Relief
    • Expansion of Outpatient Spine Care Centers Increases Market Opportunity for Sacroiliac Joint Fusion Injections and RF Ablation
    • Growing Awareness of Sacroiliac Joint Dysfunction as a Cause of Chronic Back Pain Spurs Demand for Targeted Injections and Ablation Treatments
    • Increasing Focus on Reducing Surgical Risk and Recovery Times Drives Adoption of Sacroiliac Joint Fusion Injections and RF Ablation
    • Surge in Development of Combined Injection and RF Ablation Therapies Creates New Opportunities for Integrated Pain Management Solutions
    • Rising Investment in Spine and Orthopedic Surgery Innovations Drives Growth in Sacroiliac Joint Fusion Injections and RF Ablation Technologies
    • Increasing Focus on Personalized Pain Management and Targeted Therapies Expands Market for Sacroiliac Joint Fusion Injections and RF Ablation
    • Growing Role of Regenerative Medicine and Biologics in Pain Management Expands the Reach of Sacroiliac Joint Fusion Injections
    • Surge in Medical Tourism for Spine and Orthopedic Treatments Generates Demand for Sacroiliac Joint Fusion Injections and RF Ablation Procedures
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sacroiliac Joint Fusion Injections and RF Ablation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Degenerative Sacroilitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Degenerative Sacroilitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Degenerative Sacroilitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sacral Disruption by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Sacral Disruption by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Sacral Disruption by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Trauma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • JAPAN
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • CHINA
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • EUROPE
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • FRANCE
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • GERMANY
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • INDIA
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • AFRICA
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!